Form 10-Q Panbela Therapeutics, For: Mar 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Form 10-Q Panbela Therapeutics, For: Mar 31

H.C. Wainwright Downgrades Panbella Therapeutics (PBLA) to Neutral

May 16, 2024 11:31 AM EDT

H.C. Wainwright analyst Joseph Pantginis downgraded Panbella Therapeutics (NASDAQ: PBLA) from Buy to Neutral.

The analyst comments "Yesterday after the close, Panbela announced 1Q24 results, posting 1Q24 EPS of ($2.28) compared with our estimate of ($1.23) and consensus of ($1.62). The company ended the quarter with $262,000 in cash. Per management, current cash burn... More